599 filings
Page 4 of 30
6-K
7dhz9 djn41wmc0w5t
31 Mar 22
Portage Biotech Provides Update on Clinical-Stage and Development Programs
8:00am
UPLOAD
wmddcucsj1
14 Mar 22
Letter from SEC
12:00am
20-F/A
iz7b6i4f e5
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
0jzuubnsed99elyx5rj
25 Feb 22
Current report (foreign)
5:29pm
6-K
d21eoz 5rc6ys
25 Feb 22
Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year
12:00am
UPLOAD
qx89uj5
17 Feb 22
Letter from SEC
12:00am
6-K
ln0 hl4dpva
15 Feb 22
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
8:00am
6-K
ozdc4myj7mv 9qa
23 Nov 21
Current report (foreign)
4:30pm
6-K
m0515r46xl33 4ex1z5
23 Nov 21
Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year
8:00am
6-K
enjof
30 Aug 21
Current report (foreign)
5:21pm
6-K
riybvp
30 Aug 21
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
8:00am
6-K
1fi1ktwib1a12vnbmv
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am
6-K
sqowc0 02g7gef8
28 Jul 21
Current report (foreign)
9:37am
SUPPL
xhdztjbd69fqdytac
24 Jun 21
Supplemental materials (foreign)
5:27pm
6-K
2ag a87pggbnly
24 Jun 21
Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
4:05pm
SUPPL
76kkfvgiung q368x
23 Jun 21
Supplemental materials (foreign)
4:01pm
20-F/A
t2bt9to q24zobr
26 Mar 21
Annual report (foreign) (amended)
12:00am
EFFECT
tg8dhh2uifva
9 Mar 21
Notice of effectiveness
12:15am
424B5
ve5 9mdbtq1
8 Mar 21
Prospectus supplement for primary offering
5:03pm